National University Centre for Organ Transplantation, National University Hospital, Singapore, Singapore.
World J Urol. 2019 Oct;37(10):2231-2236. doi: 10.1007/s00345-018-2566-2. Epub 2018 Nov 19.
Obesity may be a risk factor for kidney donors to develop reduced renal function. The Framingham heart study suggested that visceral adipose tissue (VAT) confers a more adverse metabolic profile compared with subcutaneous adipose tissue (SAT). Asians tend to have a higher VAT composition and it is unclear if their kidney function is affected differently. We hypothesized that Asian living kidney donors who have visceral obesity are at a higher risk of renal function deterioration 1 year after donation.
Between 2011 and 2014, we retrospectively evaluated data from 73 consecutive patients (52% male; mean age 44.9 ± 11.7 years) before they underwent donor nephrectomy and at their 1 year routine follow-up. VAT and SAT were measured at the level of the umbilicus on pre-operative computerized tomography (CT). Visceral obesity (VO) was defined as a VAT > 100 cm [2] and patients were then further divided and compared in two subgroups: VAT > 100 and < 100 cm [2]. Estimated glomerular filtration rate (eGFR, mL/min per 1.73 m [2]) was calculated using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation pre-operatively and 1 year post-operatively.
Both subgroups had similar baseline kidney function (P = NS) pre-operatively. At the 1 year follow-up, patients with VO experienced a more significant decline of renal function (109 ± 9 to 89 ± 8 mL/min per 1.73 m), compared to those without VO (111 ± 12 to 96 ± 11 mL/min per 1.73 m, P = 0.013). VO was associated with a body mass index (BMI) > 25 kg/m (P < 0.001), male gender (P < 0.001) and older age at the time of donor nephrectomy (48.0 vs 39.5 years, P = 0.01). The presence of hypertension or hyperlipidaemia pre-operatively, choice of surgical approach, and post-operative complication rates, did not differ significantly between the subgroups.
Visceral obesity as defined by VAT > 100 cm at the level of the umbilicus on cross-sectional imaging, may have a significant impact on early renal function after donor nephrectomy. Adiposity markers, as measured by cross-sectional CT imaging, may be incorporated into routine pre-operative kidney donor workup.
肥胖可能是导致肾脏捐献者肾功能下降的一个危险因素。弗雷明汉心脏研究表明,内脏脂肪组织(VAT)比皮下脂肪组织(SAT)具有更不利的代谢特征。亚洲人往往有更高的 VAT 组成,目前尚不清楚他们的肾功能是否受到不同的影响。我们假设,接受肾脏捐献的亚洲人,如果存在内脏肥胖,那么在捐献后 1 年,他们的肾功能恶化的风险更高。
在 2011 年至 2014 年期间,我们回顾性地评估了 73 名连续患者(52%为男性;平均年龄 44.9±11.7 岁)术前和 1 年常规随访时的数据。术前计算机断层扫描(CT)测量脐水平的 VAT 和 SAT。内脏肥胖(VO)定义为 VAT>100cm [2],然后将患者进一步分为两组:VAT>100cm 和<100cm [2]。术前和术后 1 年分别使用慢性肾脏病流行病学合作(CKD-EPI)方程计算估算肾小球滤过率(eGFR,mL/min/1.73m [2])。
两组患者术前的基础肾功能相似(P=NS)。在 1 年随访时,VO 患者的肾功能下降更为显著(109±9 至 89±8mL/min/1.73m),而无 VO 患者则下降较少(111±12 至 96±11mL/min/1.73m,P=0.013)。VO 与 BMI>25kg/m(P<0.001)、男性(P<0.001)和供肾切除时年龄较大(48.0 岁 vs 39.5 岁,P=0.01)相关。术前高血压或高脂血症、手术入路选择以及术后并发症发生率在两组间无显著差异。
在横断面影像学上,脐水平的 VAT>100cm 定义的内脏肥胖,可能对供肾切除后早期肾功能有显著影响。通过横断面 CT 成像测量的肥胖标志物,可能被纳入常规术前肾脏捐献者检查。